Angiopoietin‐2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma
- 16 July 2008
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 23 (7pt2), e157-e164
- https://doi.org/10.1111/j.1440-1746.2007.05175.x
Abstract
Background and Aim: Hepatocellular carcinoma (HCC) is characteristically a hypervascular tumor and its progression is known to be closely related to angiogenesis. In this study, we investigated angiopoietin‐2 (Ang‐2) and vascular endothelial growth factor (VEGF) levels in the hepatic vein draining from HCC, as well as in the peripheral vein, to evaluate their relation to clinicopathological features and prognosis. Methods: To obtain hepatic venous blood samples, a catheter was placed into the main branch of the hepatic vein draining from HCC in 21 patients. The Ang‐2 and VEGF levels in both the hepatic and peripheral veins were investigated. Furthermore, Ang‐2 mRNA expression in surgically resected HCC was evaluated by quantitative reverse‐transcription polymerase chain reaction (RT‐PCR), as well as microvessel density (MVD) by CD34 immunostaining. Results: Ang‐2 levels in the hepatic vein significantly correlated with Ang‐2 mRNA expression in HCC, but Ang‐2 levels in the peripheral vein did not correlate. Furthermore, a significant correlation was found between hepatic venous Ang‐2 and MVD levels, whereas there was no significant correlation with hepatic venous VEGF levels. When hepatic venous Ang‐2 levels were compared with clinicopathological features, a significant relationship was found between high Ang‐2 levels and portal vein invasion. The survival for patients in the high hepatic venous Ang‐2 group was significantly poorer when compared with the low group. Conclusion: Preoperative hepatic venous Ang‐2 levels may be a good predictor for portal vein invasion and also prognosis in patients with HCC.Keywords
This publication has 34 references indexed in Scilit:
- Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in miceGut, 2005
- Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinomaJournal of Hepatology, 2004
- Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinomaHepatology, 2003
- Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the Angiopoietin receptor Tie-2Oncogene, 1999
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Biologic significance of angiopoietin-2 expression in human hepatocellular carcinomaJCI Insight, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formationNature, 1995
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971